Patents
Patents for C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
03/2003
03/26/2003EP1294716A1 Lactam inhibitors of factor xa and method
03/26/2003EP1294698A1 Fused azepine derivatives and their use as antidiuretic agents
03/26/2003EP1294697A1 1,2,3,5-tetrahydrobenzo[c]azepin-4-one derivatives having muscarinic antagonist activity
03/26/2003EP1102720B1 Method for distilling ammonia
03/26/2003EP0885186B1 Amino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them
03/20/2003US20030055245 Kinetic resolution of a intermediate useful in the production of benazepril and analogues thereof
03/20/2003US20030055076 Novel compounds, their preparation and use
03/20/2003US20030055041 Certain substituted caprolactam carbonates and ethers, pharmaceutical compositions containing them and their use in treating tumors
03/20/2003US20030054200 Organic electroluminescence device
03/18/2003US6534517 A polycyclic or heteropolycyclic compound containing amide or carboxy groups useful in the treatment and/or prevention of conditions mediated by nuclear receptors, in particular the peroxisome proliferator-activated receptor(PPAR)
03/18/2003US6534497 Substitute 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
03/18/2003CA2162708C Bicyclic amide derivatives and their use as muscle relaxants
03/13/2003US20030050309 A gelatinase inhibitor for modulating the activity of a dopamine, serotonin, or norepinephrine receptor or transporter
03/13/2003US20030050251 A polypeptide which inhibits or reduces tumor progression and/or metastasis
03/12/2003EP1289966A1 SUBSTITUTED LACTAMS AS INHIBITORS OF A$g(b) PROTEIN PRODUCTION
03/12/2003EP1289965A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
03/12/2003EP1289964A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
03/12/2003EP1289949A1 Method for the production of caprolactam
03/12/2003EP1289948A1 Method for purifying lactams
03/06/2003WO2003018562A1 Process for distilling alkaline caprolactam product at reduced pressure
03/06/2003WO2003018550A1 Process for recovering caprolactam from aqueous caprolactam product using in situ prepared alkali amino caproate
03/06/2003WO2002047671A3 Lactam compound to inhibit beta-amyloid peptide release or synthesis
03/06/2003US20030045517 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists
03/06/2003US20030044399 Method of treatment
03/05/2003EP1288203A1 Cyclic nitrones and pharmaceutical compositions containing them
03/05/2003EP1288198A1 Process for the production of sulfonic esters
03/05/2003EP1286963A1 Method for separating ammonia from solutions containing caprolactam and ammonia
03/05/2003EP1286673A2 Ligands of integrin receptors
03/05/2003EP0942901B1 Cyclic imines as pesticides
02/2003
02/27/2003WO2002096881A8 Method for preparation of 10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide and 10,11-dihydro-10-0x0-5h-dibenz/b,f/azepine-5-carboxamide
02/27/2003WO2002051813A3 PROCESS FOR THE PREPARATION OF α-AMINOSUBSTITUTED CARBOXYLIC ACID AMIDES
02/27/2003US20030040512 Pharmaceutical composition with protective action against oxidative/toxic substances, especially cardiotoxic substances
02/26/2003EP1284730A1 Aralkyl ester soft drugs
02/26/2003EP1112456B1 Tube for lining pipes and channels, and a method and device for the production thereof
02/26/2003EP1042297B1 Carboxyl acid substituted heterocycles as metalloproteinase inhibitors
02/26/2003CN1399634A Hydroxyalkanoyl aminolactams and related structure as inhibitors of A beta protein production
02/25/2003US6525202 Cyclic amine phenyl beta-3 adrenergic receptor agonists
02/20/2003WO2003014110A1 Benzazepine derivative, process for producing the same, and use
02/20/2003WO2003013545A1 Novel benzo-fused heterocycles as endothelin antagonisits
02/20/2003US20030036659 Method for the production of n-alkenyl amides
02/20/2003CA2456754A1 Benzazepine derivative, process for producing the same, and use
02/20/2003CA2454417A1 Novel benzo-fused heterocycles as endothelin antagonists
02/18/2003US6521779 Hemihydrogenation method for dinitriles
02/18/2003US6521752 Process to separate linear alkyl 5-formylvalerate
02/18/2003US6521613 N-substituted polyalkylene oxide derivatives of cyclic amides used for enhancing the penetration or transport of pharmacologically active substances through skin or membranes
02/13/2003WO2003011834A1 Novel vinyl n-(2-benzoylphenyl)-l-tyrosine derivatives and their use as antidiabetics etc
02/13/2003US20030032800 Dibenzo(b,f)azepine derivatives and their preparation
02/12/2003EP1283199A1 Melanin-concentrating hormone antagonist
02/12/2003EP1282604A1 Substituted caprolactam carbonates and ethers and their use as anti-tumor agents
02/12/2003CN1101382C Derivatives of 10,11-dihydro-10-oxo-5H-dibenz/b.f/azepine-5-carboxamide
02/11/2003CA2337321C Method for distilling ammonia
02/11/2003CA2165894C Process for the purification of 5h-dibenz(b,f)azepine
02/06/2003US20030028035 By reacting the corresponding NH-amides with acetylenes in the liquid phase using a basic alkali metal compound as catalyst and as cocatalyst (di- or tri-)1,4-butanediol mono- and diethers; N-vinyl-2-pyrrolidone from pyrrolidone
02/06/2003US20030027862 Amino-and amido-diphenyl ethers
02/06/2003US20030027812 Useful for treating or preventing a disorder or condition selected from hypertension, depression, anxiety, phobias, post trauma stress, sexual disfunction, eating disorder, obesity, Alzheimer's disease, Parkinson's disease etc.
02/05/2003EP1280777A1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
02/05/2003EP1280768A1 Method for producing caprolactam from 6-aminocapronitrile
02/05/2003EP1280767A1 Method for producing caprolactam on the basis of 6-aminocapronitrile and subsequent purification by crystallization
02/05/2003EP1086078B1 Neuropeptide y5 receptor antagonists
02/05/2003CN1395467A Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents
02/04/2003US6514990 Pharmaceutically active compounds and methods of use
02/04/2003US6514965 Substituted 1-benzazepines and derivatives thereof
02/04/2003US6514964 Treating diseases, conditions or disorders mediated by integrin receptors, such as vitronectin and fibronectin receptors
01/2003
01/31/2003WO2002012169A1 Amino diphenyl ethers and amido diphenyl ethers
01/31/2003CA2417880A1 Amino diphenyl ethers and amido diphenyl ethers
01/30/2003WO2002047679A8 Nonpeptide agonists and antagonists of vasopressin receptors
01/30/2003US20030023083 Method for separating an azepine derivative out of a mixture containing an amine an azepine derivative
01/29/2003EP1278727A1 Method for producing cyclic lactams
01/29/2003EP1278726A1 Method for producing cyclic lactams
01/29/2003EP1278502A2 Protease inhibitors
01/29/2003CN1394204A Dibenzo [b,f] azepine intermediates
01/29/2003CN1100040C Hydrofinishing method of caprolactam
01/23/2003WO2002034760A3 Compounds and methods
01/22/2003EP1277755A1 OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT WITH AXIAL ASYMMETRY, PROCESS FOR PRODUCING THE SAME, AND APPLICATION TO ASYMMETRIC SYNTHESIS OF $g(a)-AMINO ACID DERIVATIVE
01/21/2003US6509356 1-(4-(Substituted alkoxy)benzyl)naphthalene compounds having estrogen inhibitory activity
01/21/2003US6509333 1-(3-methyl-1-(1,3-dihydro-1-methyl-2-oxo-5-phenyl-2H-1,4 -benzodiazepin-3-ylcarbamoyl)-butyl)-cyclopent-3-enecarboxylic amide, for example; gamma-secretase inhibitors; Alzhemier's disease, Down's Syndrome
01/21/2003US6509331 Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
01/16/2003WO2003003972A2 Kinetic resolution of a intermediate useful in the production of benazepril and analogues thereof
01/16/2003WO2002012196A3 Lactam compounds and their use as inhibitors of serine proteases and method
01/16/2003US20030013702 Agents and methods for treatment of cancer
01/15/2003EP0925287B1 Heterocyclic metalloprotease inhibitors
01/15/2003EP0820451B1 Novel heterocyclic compounds
01/15/2003EP0729468B1 Non-peptide tachykinin receptor antagonists
01/15/2003CN1098840C Dinaphtazepinium salts useful as enantioselective epoxidation catalysts
01/08/2003EP0863878B1 Cyclic nitrones and pharmaceutical compositions containing them
01/07/2003US6503902 Treatment of neurological disorders related to beta -amyloid production such as Alzheimer's disease and Down's Syndrome.
01/07/2003US6503898 Administering 4,7-dibenzyl-5,6-dihydroxy-N,N*-di(m-aminobenzyl)--1,3-diazepin-2-one or salt to treat human immunodeficiency virus infection
01/07/2003US6503897 N-Formylhydroxylamine derivatives; veterinary medicine; grampositive and gramnegative bacteria
01/03/2003WO2002060870A3 Delta agonist analgesics
01/02/2003US20030004284 Melting, crystallizing, separation
01/02/2003US20030004154 New crystal forms of oxcarbazepine and processes for their preparation
01/02/2003EP1268450A1 Lactams substituted by cyclic succinates as inhibitors of a-beta protein production
01/02/2003EP1268434A1 Cyclic lactams as inhibitors of a-beta protein production
01/02/2003EP1268433A1 Cyclic lactams as inhibitors of a-beta-protein production
01/02/2003EP1268429A1 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
01/02/2003EP1268425A2 Carbamate caspase inhibitors and uses thereof
01/02/2003EP1268412A1 Sulphonamido-substituted bridged bicycloalkyl derivatives
01/02/2003EP1268402A2 Process for preparing 6-aminocaproamide
01/02/2003EP1267855A2 Vasopeptidase inhibitors to treat isolated systolic hypertension
01/01/2003CN1388121A Improved low-temperature energy source utilization process in caprolactam production
1 ... 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 ... 88